JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142818

Methoxy-X04, amyloid beta fluorescent marker

Be the first to review this product! Submit a review

|

(5 Publications )

MW 344.4 Da, Purity >98%. Blood-brain barrier permeable amyloid β fluorescent marker. Blue fluorophore. Derivative of Congo Red (ab145645) and Chrysamine G. Selectively binds fibrillar β-sheet deposits with high affinity (Ki = 26.8 nM). Detects plaques, tangles and cerebrovascular amyloid in vivo. .

View Alternative Names

A BETA, A4 amyloid protein, A4_HUMAN, AAA, ABPP, AD1, AICD-50, AICD-57, AICD-59, AID(50), AID(57), AID(59), APP, APPI, Alzheimer disease amyloid protein, Amyloid beta (A4) precursor protein, Amyloid beta A4 protein, Amyloid beta protein, Amyloid intracellular domain 50, Amyloid intracellular domain 57, Amyloid intracellular domain 59, Amyloid precursor protein, Beta-APP40, Beta-APP42, Beta-amyloid precursor protein, C31, CTFgamma, CVAP, Cerebral vascular amyloid peptide, Gamma-CTF(50), Gamma-CTF(57), Gamma-CTF(59), PN 2, PN-II, PreA4, Protease nexin-II, S-APP-alpha, S-APP-beta, beta-amyloid peptide, peptidase nexin-II, sAPP

1 Images
Chemical Structure - Methoxy-X04, amyloid beta fluorescent marker (AB142818)
  • Chemical Structure

Lab

Chemical Structure - Methoxy-X04, amyloid beta fluorescent marker (AB142818)

2D chemical structure image of ab142818, Methoxy-X04, amyloid beta fluorescent marker

Key facts

CAS number

863918-78-9

Purity

>98%

Molecular weight

344.4 Da

Molecular formula

C<sub>2</sub><sub>3</sub>H<sub>2</sub><sub>0</sub>O<sub>3</sub>

PubChem

16049314

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 20 mM

Biochemical name

Methoxy-X04

Biological description

Blood-brain barrier permeable amyloid β fluorescent marker. Blue fluorophore. Derivative of Congo Red (ab145645) and Chrysamine G. Selectively binds fibrillar β-sheet deposits with high affinity (Ki = 26.8 nM). Detects plaques, tangles and cerebrovascular amyloid in vivo.

Canonical smiles

COC1=C(C=CC(=C1)C=CC2=CC=C(C=C2)O)C=CC3=CC=C(C=C3)O

Isomeric smiles

COC1=C(C=CC(=C1)/C=C/C2=CC=C(C=C2)O)/C=C/C3=CC=C(C=C3)O

InChi

InChI=1S/C23H20O3/c1-26-23-16-19(3-2-17-6-12-21(24)13-7-17)5-11-20(23)10-4-18-8-14-22(25)15-9-18/h2-16,24-25H,1H3/b3-2+,10-4+

InChiKey

FGYNZFHVGOFCMD-KHVHPYDTSA-N

IUPAC Name

4-[(E)-2-[4-[(E)-2-(4-hydroxyphenyl)ethenyl]-3-methoxyphenyl]ethenyl]phenol

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 2664 Methoxy-X04. 2664-25 is the same size as the 25 mg size of ab142818.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Handling instructions

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Amyloid Precursor Protein (APP) also known as amyloid protein is a transmembrane protein that is approximately 695 to 770 amino acids in length depending on the isoform. The molecular mass of APP can vary but typically falls around 100 to 140 kDa. It is heavily expressed in the central nervous system particularly in neurons but also in other tissues like muscle and kidney. The APP undergoes proteolytic processing which leads to the generation of various fragments including beta-amyloid peptides.
Biological function summary

The processing of APP plays a fundamental role in neuronal growth survival and repair. APP is cleaved into fragments that can regulate synaptic function and plasticity. It does not operate as a part of a complex but interacts with various cellular components. The protein participates in signaling pathways influencing cellular adhesion motility and neurite outgrowth. APP’s numerous interaction partners facilitate its involvement in different cellular processes highlighting its critical role in normal cell function.

Pathways

The APP is a central component in the amyloidogenic pathway where its cleavage by beta-secretase and gamma-secretase yields beta-amyloid. This pathway is one of two primary metabolic routes for APP—alternative enzymatic processing through the non-amyloidogenic pathway precludes beta-amyloid formation releasing peptides that do not aggregate. Enzymes like BACE1 (beta-secretase 1) and presenilin are important in the amyloidogenic pathway directly resulting in the production of the neurotoxic amyloid beta-peptide.

APP is intensely linked to Alzheimer's disease and cerebral amyloid angiopathy. Accumulation of beta-amyloid peptides formed from APP cleavage is a hallmark of Alzheimer's disease leading to plaque formation in the brain. This aggregation impacts neuronal function and is associated with neurodegenerative processes. Interactions with proteins like tau are significant as tau also plays an essential role in Alzheimer's disease pathology. Misprocessing of APP and the resulting beta-amyloid aggregates are also contributors to cerebral amyloid angiopathy where deposits within cerebrovascular walls compromise vascular integrity.

Product protocols

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Journal of neural engineering 20: PubMed37531953

2023

Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Steven M Wellman,Olivia A Coyne,Madeline M Douglas,Takashi D Y Kozai

Cells 12: PubMed36611872

2022

Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model.

Applications

Unspecified application

Species

Unspecified reactive species

Jasenka Rudan Njavro,Marija Vukicevic,Emma Fiorini,Lina Dinkel,Stephan A Müller,Anna Berghofer,Chiara Bordier,Stanislav Kozlov,Annett Halle,Katrin Buschmann,Anja Capell,Camilla Giudici,Michael Willem,Regina Feederle,Stefan F Lichtenthaler,Chiara Babolin,Paolo Montanari,Andrea Pfeifer,Marie Kosco-Vilbois,Sabina Tahirovic

eLife 11: PubMed36040311

2022

IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Niklas Lonnemann,Shirin Hosseini,Melanie Ohm,Robert Geffers,Karsten Hiller,Charles A Dinarello,Martin Korte

International journal of molecular sciences 21: PubMed32138161

2020

Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Pedram Honarpisheh,Caroline R Reynolds,Maria P Blasco Conesa,Jose F Moruno Manchon,Nagireddy Putluri,Meenakshi B Bhattacharjee,Akihiko Urayama,Louise D McCullough,Bhanu P Ganesh

Journal of neuropathology and experimental neurology 61:797-805 PubMed12230326

2002

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Applications

Unspecified application

Species

Unspecified reactive species

William E Klunk,Brian J Bacskai,Chester A Mathis,Stephen T Kajdasz,Megan E McLellan,Matthew P Frosch,Manik L Debnath,Daniel P Holt,Yanming Wang,Bradley T Hyman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com